# Feasibility of a Lateral Flow Urine LAM Test for Diagnosis of Tuberculosis in South Africa

> **NCT01693224** · NA · UNKNOWN · sponsor: **Tuberculosis Clinical Diagnostics Research Consortium** · enrollment: 512 (actual)

## Conditions studied

- Tuberculosis
- Tuberculosis, Pulmonary
- Tuberculosis, Miliary

## Interventions

- **DEVICE:** Alere "Determine" lateral-flow urine lipoarabinomannan assay
- **DEVICE:** Alere "Clearview" ELISA urine LAM assay
- **DEVICE:** Cepheid Xpert MTB/Rif assay

## Key facts

- **NCT ID:** NCT01693224
- **Lead sponsor:** Tuberculosis Clinical Diagnostics Research Consortium
- **Sponsor class:** NETWORK
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2011-04
- **Primary completion:** 2013-02
- **Final completion:** 2013-02
- **Target enrollment:** 512 (ACTUAL)
- **Last updated:** 2012-09-26

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01693224

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01693224, "Feasibility of a Lateral Flow Urine LAM Test for Diagnosis of Tuberculosis in South Africa". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT01693224. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*